FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation. The podcast also will have bonus episodes to cover breaking news. Podcast guests analyze FDA regulations, guidances, and policy developments and engage in insightful and revealing conversations with host Wayne Pines, former FDA associate commissioner and author/editor of 16 books about FDA. Subscribers to the podcast include regulatory affairs specialists, food and drug attorneys, policymakers, government officials, strategic planners, and IT and cybersecurity professionals. more

STAT's weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. more

MAHA Action is dedicated to organizing and empowering Americans to advocate for this once in a generation opportunity to reverse the chronic disease epidemic. more

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor more

Health on the Hill provides updates on the current happenings in health care within the Federal Government and on Capitol Hill. more

An hour of medical questions, answers, debate, dialogue, discussion, & health in the news.

A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products. more

Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news. more

Food Safety Matters is a podcast for food safety professionals hosted by the Food Safety Magazine editorial team the leading media brand in food safety for over 20 years. Each episode will feature a conversation with a food safety professional sharing their experiences and insights into the important job of safeguarding the world's food supply. more

The Life Science Rundown is a podcast for life science professionals hosted by The FDA Group. We dive deep into topics across the RA/QA/Clinical space, covering news, exploring trends, and picking the brains of expert guests. more

Navigate every market. Accelerate every launch.Medical Device Global Market Access by Pure Global is the audio briefing that turns the world's most confusing regulatory pathways into clear, actionable roadmaps. If you're a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut.Why listen? • Step-by-step playbooks We decode EU MDR, U.S. 510(k), Brazil's ANVISA, China's NMPA, and 25 other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence Every episode covering the week's new guidances, standards, and enforcement trends so you're always ahead of the curve. • Actionable templates From clinical evaluation checklists to technical-file skeletons, we break down the documents you'll need and the pitfalls reviewers love to flag. • AI-powered insights Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won't hear at conferences—or from competitors.What you'll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a 'reg-first' QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regionsWhether you're plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue.⸻Brought to you by Pure Global the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today. more

Don and Ben talk to each other and the occasional guest about food safety in the news. They also respond to listener feedback. more

Commissioner Makary and other members of FDA leadership, as well as guests, engage in timely and frank discussions to bring you an inside look at the current happenings at the FDA. more

With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs and the insurance industry increasing the use of more restrictive barriers to access, those who need these medicines—the patients themselves—are caught in the middle, not only shouldering the cost of higher copays and deductibles, but for many, rationing or even abandoning treatment altogether. While manufacturers invest in programs to help navigate the challenges impeding access and affordability, the entire healthcare industry can agree -- the status quo is unsustainable. There has to be a better way. And two industry veterans have joined forces to co-host a new interview-focused podcast to help shape the future of patient access and affordability. more

Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring. The views and opinions expressed in the podcast are those of the hosts and guests respectively and, unless otherwise stated, do not represent the position of any institution to which they are affiliated. more

The Global Medical Device Podcast, powered by Greenlight Guru, is where today's brightest minds in the medical device industry go to get their most useful and actionable insider knowledge, direct from some of the world's leading medical device experts and companies. more

'Not So Different,' a podcast from The Center for Biosimilars, brings you expert viewpoints from physicians, pharmacists, patients, developers, and other stakeholders in the complex world of biosimilar therapies. more

RCA Radio covers the latest news and challenges in regulatory, compliance, and quality assurance facing the medical device, pharmaceutical, and biologic industries. In each episode, join Regulatory Compliance Associates® (RCA) and industry thought leaders as we navigate the issues that matter to you most. more

Welcome to 'No Ordinary Subjects,' a new health, medicine, and clinical research-focused podcast with a mission of shining a bright light on overlooked issues and underrepresented perspectives. Here, we aim to explore the facets and implications of diversity, equity and inclusion from the perspectives of all stakeholders. From those providing care across specialties, to individuals working tirelessly to bring new therapies to market, and the medical heroes who decide to participate in clinical trials. Whether patients or healthy volunteers— just don't call us 'subjects!' Guests are the extraordinary humans in every sector of this ecosystem who are making progress possible for the rest of us. Join me on this collective journey toward better outcomes — for ALL. Feedback and suggestions for podcast topics and guests are welcome! Please share the links with those you care about, and subscribe to catch every episode on your favorite platform. Thanks in advance! #beyondlipservice more

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development. more